Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dongzhou Ma"'
Publikováno v:
Clinics, Vol 76 (2021)
OBJECTIVES: To investigate the molecular mechanism of edaravone (EDA) in improving the post-traumatic brain injury (TBI) dysfunction in learning and memory. METHODS: In vitro and in vivo TBI models were established using hydrogen peroxide (H2O2) trea
Externí odkaz:
https://doaj.org/article/7379d7e6745c4cb089396c6134721e23
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
To explore the role and mechanism of CERS1 in hypophysoma and investigate whether CERS1 overexpression can change the autophagy process of hypophysoma, and then to explore whether CERS1’s effect was regulated by the PI3K/AKT signaling pathway. West
Externí odkaz:
https://doaj.org/article/2c9b01dd10dc4ed28f8866e0a2ccbe6f
Publikováno v:
European Neurology. 83:73-79
Objective: The present study aimed to explore the effects of edaravone on neurological function, tumor necrosis factor α (TNF-α), and interleukin (IL)-8 levels in patients with cerebral infarction. Methods: A total of 96 patients with cerebral in
Publikováno v:
Experimental and Therapeutic Medicine.
Long non-coding RNAs (lncRNAs) are hypothesized to regulate numerous biological behaviors in human cancers. The present study aimed to explore the roles of lncRNA bladder cancer associated transcript 1 (BLACAT1) in glioma. The expression of BLACAT1 i
Publikováno v:
Technology in Cancer Research & Treatment
Technology in Cancer Research & Treatment, Vol 19 (2020)
Technology in Cancer Research & Treatment, Vol 19 (2020)
To explore the role and mechanism of CERS1 in hypophysoma and investigate whether CERS1 overexpression can change the autophagy process of hypophysoma, and then to explore whether CERS1’s effect was regulated by the PI3K/AKT signaling pathway. West
Publikováno v:
International journal of clinical and experimental pathology. 10(11)
MicroRNAs (miRNAs) are a class of small non-coding RNA molecules, about 21-25 nucleotides in length. Accumulating evidence demonstrated that dysregulation or dysfunction of miRNAs are involved in various diseases, including cancer. MiR-143, recently